We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,486

Microsoft Antitrust Suit Against InterDigital Stands, Judge Says
  • McDermott Will & Emery
  • USA
  • April 18 2016

On April 13, 2016, the US District Court for the District of Delaware denied InterDigital's motion to dismiss an antitrust suit filed by Microsoft


FTC Challenges "No-AG" Agreement as Illegal Reverse Payment
  • Cooley LLP
  • USA
  • April 6 2016

On March 30 the US Federal Trade Commission filed suit in federal court alleging that settlements of patent litigation in the pharmaceutical industry


Royalty obligations when patents are revoked
  • Bristows LLP
  • European Union, USA
  • April 6 2016

Claire Smith says that although the Advocate General's opinion in Genentech may not come as much of a surprise, it highlights to lawyers the


Injunctive Relief for Standard Essential Patents Holders Will be Restricted
  • King & Wood Mallesons
  • China, European Union, USA
  • April 6 2016

Whether standard essential patents holders (hereinafter "SEP holders") who have made commitments to license the patents on fair, reasonable and


A New Normal? Challenges to Market Definition Find a Foothold at 12(b)(6) Stage
  • Proskauer Rose LLP
  • USA
  • April 5 2016

Recent federal court opinions dismissing cases under Rule 12(b)(6) may provide an early off-ramp for antitrust defendants where a roadblock has often


FTC’s Latest “Pay for Delay” Action Focuses on Noncash “Payments” and New “Product Hopping” Theory of Harm
  • Baker & Hostetler LLP
  • USA
  • April 4 2016

The Federal Trade Commission (FTC) filed an antitrust complaint this week against Endo Pharmaceuticals and several generic companies, alleging that


Potential Antitrust Implications of Grantbacks
  • Weil Gotshal & Manges LLP
  • USA
  • March 29 2016

Grantbacks are a relatively common licensing provision in which patent holders require a licensee to “grant back” certain rights to improvements or


Federal Circuit Upholds District Court Judgment of Inequitable Conduct and Award of Attorney’s Fees for a Walker Process Antitrust Violation
  • Knobbe Martens Olson & Bear LLP
  • USA
  • March 24 2016

In Transweb, LLC v. 3M Innovative Properties Co., Appeal No. 2014-1646, the Federal Circuit affirmed the district court's: (1) finding of inequitable


TransWeb, LLC v. 3M Company, et al.
  • Winston & Strawn LLP
  • USA
  • March 21 2016

The patentee claimed infringement of several patents concerning processes for manufacturing respirator filters. The alleged infringer sued for


FTC’s Amicus Brief in Wellbutrin XL Appeal Highlights Significance for Interpretation of Actavis
  • Baker & Hostetler LLP
  • USA
  • March 18 2016

The FTC has recently weighed in again on the evolving interpretation of the Supreme Court's 2013 opinion in FTC v. Actavis, 133 S. Ct. 2223 (2013